Transthyretin-IN-4 is a bivalent inhibitor targeting transthyretin (TTR) amyloidosis with a bIC50 of 0.09 µM. This compound is instrumental in researching fatal heart failure with preserved ejection fraction (HFpEF) and associated fatal arrhythmias. Its ability to modulate TTR dynamics makes it a valuable tool for investigating the pathophysiology of TTR-related diseases.
Transthyretin-IN-4 is a bivalent inhibitor targeting transthyretin (TTR) amyloidosis with a bIC50 of 0.09 µM. This compound is instrumental in researching fatal heart failure with preserved ejection fraction (HFpEF) and associated fatal arrhythmias. Its ability to modulate TTR dynamics makes it a valuable tool for investigating the pathophysiology of TTR-related diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: